Director Marino Zerial elected as a new member of the Leopoldina
The German National Academy of Sciences Leopoldina has elected the Dresden and Italian cell biologist Marino Zerial as one of its members. Currently Director of Human Technopole, he is also one of the founding directors of the Max Planck Institute for Molecular Cell Biology and Genetics (MPI-CBG). The German National Academy of Sciences Leopoldina brings together researchers with special expertise in their respective fields. The criteria for membership are outstanding scientific achievements. Election to the ranks of the Leopoldina is considered one of the highest honors for scientists.
The Leopoldina recognized Marino Zerial for his outstanding achievements in the field of cell biology and elected him to the section Genetics / Molecular Biology and Cell Biology. One of his most significant discoveries is about the key role of Rab5 protein in the molecular mechanism of endocytosis and membrane transport.
Prior to his membership in the Leopoldina, Marino Zerial was awarded the Gottfried Wilhelm Leibniz Prize in 2008 and has been honored with the membership of the Istituto Veneto di Scienze, Lettere ed Arti in 2019. In 2021, he became an International Honorary Member of the American Academy of Arts and Sciences.
“The election to the Leopoldina is a great honor for me,” says Marino Zerial. “I am excited for the chance to join the oldest Academy in the life science and for the chance to contribute my knowledge for policy makers and society.”
As the German National Academy of Sciences, the Leopoldina provides independent science-based policy advice on socially relevant issues. For this purpose, the Academy develops interdisciplinary statements based on scientific findings. The Leopoldina represents German science in international bodies, including science-based advice to the annual G7 summits. It has 1,600 members from more than 30 countries and brings together expertise from almost all fields of research. It was founded in 1652 and was named Germany’s National Academy of Sciences in 2008. Each year, about 50 scientists are elected to the Academy for life in a multi-step selection process. Since the academy was founded, more than 7,000 individuals have been accepted into its ranks. Among them were Marie Curie, Charles Darwin, Albert Einstein, Johann Wolfgang von Goethe, Alexander von Humboldt, Justus von Liebig and Max Planck.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.